aluates Reports

$ 0.0

Automative

Global Injectable Peptides Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-38B18216

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BUY CHAPTERS

Global Injectable Peptides Market Research Report 2025

Code: QYRE-Auto-38B18216

Report

May 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

Roche

J & J

Injectable Peptides Market Size

The global market for Injectable Peptides was valued at US$ 35190 million in the year 2024 and is projected to reach a revised size of US$ 47050 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Injectable Peptides Market

Peptide-based injectable drugs refer to medications that contain peptides as their active ingredients and are administered via injection. Peptides are short chains of amino acids, which are the building blocks of proteins. They play crucial roles in various biological processes and can be used therapeutically to target specific cellular pathways or receptors.

Injectable peptide drugs offer several advantages over other administration routes, such as oral or topical delivery. When injected, peptides can bypass the gastrointestinal tract, avoiding issues such as degradation by stomach acid or poor absorption. Additionally, injections can provide a more rapid and direct delivery of the drug into the bloodstream, allowing for faster onset of action.

This report aims to provide a comprehensive presentation of the global market for Injectable Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Peptides.

The Injectable Peptides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Peptides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injectable Peptides Market Report

Report Metric	Details
Report Name	Injectable Peptides Market
Accounted market size in year	US$ 35190 million
Forecasted market size in 2031	US$ 47050 million
CAGR	4.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Brand Generic Drug
Segment by Application	Cancer Metabolic Disorders Central Nervous System Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Roche, J & J
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Peptides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Injectable Peptides Market growing?

Ans: The Injectable Peptides Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Injectable Peptides Market size in 2031?

Ans: The Injectable Peptides Market size in 2031 will be US$ 47050 million.

Who are the main players in the Injectable Peptides Market report?

Ans: The main players in the Injectable Peptides Market are Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Roche, J & J

What are the Application segmentation covered in the Injectable Peptides Market report?

Ans: The Applications covered in the Injectable Peptides Market report are Cancer, Metabolic Disorders, Central Nervous System, Other

What are the Type segmentation covered in the Injectable Peptides Market report?

Ans: The Types covered in the Injectable Peptides Market report are Brand, Generic Drug

Recommended Reports

Injectable Drug Markets

Peptide Industry

Related Drug Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injectable Peptides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Brand

1.2.3 Generic Drug

1.3 Market by Application

1.3.1 Global Injectable Peptides Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Injectable Peptides Market Perspective (2020-2031)

2.2 Global Injectable Peptides Growth Trends by Region

2.2.1 Global Injectable Peptides Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Injectable Peptides Historic Market Size by Region (2020-2025)

2.2.3 Injectable Peptides Forecasted Market Size by Region (2026-2031)

2.3 Injectable Peptides Market Dynamics

2.3.1 Injectable Peptides Industry Trends

2.3.2 Injectable Peptides Market Drivers

2.3.3 Injectable Peptides Market Challenges

2.3.4 Injectable Peptides Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Injectable Peptides Players by Revenue

3.1.1 Global Top Injectable Peptides Players by Revenue (2020-2025)

3.1.2 Global Injectable Peptides Revenue Market Share by Players (2020-2025)

3.2 Global Injectable Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Injectable Peptides Revenue

3.4 Global Injectable Peptides Market Concentration Ratio

3.4.1 Global Injectable Peptides Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injectable Peptides Revenue in 2024

3.5 Global Key Players of Injectable Peptides Head office and Area Served

3.6 Global Key Players of Injectable Peptides, Product and Application

3.7 Global Key Players of Injectable Peptides, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Peptides Breakdown Data by Type

4.1 Global Injectable Peptides Historic Market Size by Type (2020-2025)

4.2 Global Injectable Peptides Forecasted Market Size by Type (2026-2031)

5 Injectable Peptides Breakdown Data by Application

5.1 Global Injectable Peptides Historic Market Size by Application (2020-2025)

5.2 Global Injectable Peptides Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Injectable Peptides Market Size (2020-2031)

6.2 North America Injectable Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Injectable Peptides Market Size by Country (2020-2025)

6.4 North America Injectable Peptides Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Injectable Peptides Market Size (2020-2031)

7.2 Europe Injectable Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Injectable Peptides Market Size by Country (2020-2025)

7.4 Europe Injectable Peptides Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Injectable Peptides Market Size (2020-2031)

8.2 Asia-Pacific Injectable Peptides Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Injectable Peptides Market Size by Region (2020-2025)

8.4 Asia-Pacific Injectable Peptides Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Injectable Peptides Market Size (2020-2031)

9.2 Latin America Injectable Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Injectable Peptides Market Size by Country (2020-2025)

9.4 Latin America Injectable Peptides Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Injectable Peptides Market Size (2020-2031)

10.2 Middle East & Africa Injectable Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Injectable Peptides Market Size by Country (2020-2025)

10.4 Middle East & Africa Injectable Peptides Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Injectable Peptides Introduction

11.1.4 Sanofi Revenue in Injectable Peptides Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Injectable Peptides Introduction

11.2.4 Teva Revenue in Injectable Peptides Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Injectable Peptides Introduction

11.3.4 Novo Nordisk Revenue in Injectable Peptides Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Injectable Peptides Introduction

11.4.4 Takeda Revenue in Injectable Peptides Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Injectable Peptides Introduction

11.5.4 Eli Lilly Revenue in Injectable Peptides Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Injectable Peptides Introduction

11.6.4 AstraZeneca Revenue in Injectable Peptides Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Injectable Peptides Introduction

11.7.4 Novartis Revenue in Injectable Peptides Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Injectable Peptides Introduction

11.8.4 AbbVie Revenue in Injectable Peptides Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Ipsen

11.9.1 Ipsen Company Details

11.9.2 Ipsen Business Overview

11.9.3 Ipsen Injectable Peptides Introduction

11.9.4 Ipsen Revenue in Injectable Peptides Business (2020-2025)

11.9.5 Ipsen Recent Development

11.10 Ferring

11.10.1 Ferring Company Details

11.10.2 Ferring Business Overview

11.10.3 Ferring Injectable Peptides Introduction

11.10.4 Ferring Revenue in Injectable Peptides Business (2020-2025)

11.10.5 Ferring Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Injectable Peptides Introduction

11.11.4 Merck Revenue in Injectable Peptides Business (2020-2025)

11.11.5 Merck Recent Development

11.12 The Medicines

11.12.1 The Medicines Company Details

11.12.2 The Medicines Business Overview

11.12.3 The Medicines Injectable Peptides Introduction

11.12.4 The Medicines Revenue in Injectable Peptides Business (2020-2025)

11.12.5 The Medicines Recent Development

11.13 Roche

11.13.1 Roche Company Details

11.13.2 Roche Business Overview

11.13.3 Roche Injectable Peptides Introduction

11.13.4 Roche Revenue in Injectable Peptides Business (2020-2025)

11.13.5 Roche Recent Development

11.14 J & J

11.14.1 J & J Company Details

11.14.2 J & J Business Overview

11.14.3 J & J Injectable Peptides Introduction

11.14.4 J & J Revenue in Injectable Peptides Business (2020-2025)

11.14.5 J & J Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

Roche

J & J

List of Tables

Table 1. Global Injectable Peptides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Brand

Table 3. Key Players of Generic Drug

Table 4. Global Injectable Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Injectable Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Injectable Peptides Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Injectable Peptides Market Share by Region (2020-2025)

Table 8. Global Injectable Peptides Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Injectable Peptides Market Share by Region (2026-2031)

Table 10. Injectable Peptides Market Trends

Table 11. Injectable Peptides Market Drivers

Table 12. Injectable Peptides Market Challenges

Table 13. Injectable Peptides Market Restraints

Table 14. Global Injectable Peptides Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Injectable Peptides Market Share by Players (2020-2025)

Table 16. Global Top Injectable Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2024)

Table 17. Ranking of Global Top Injectable Peptides Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Injectable Peptides Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Injectable Peptides, Headquarters and Area Served

Table 20. Global Key Players of Injectable Peptides, Product and Application

Table 21. Global Key Players of Injectable Peptides, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Injectable Peptides Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Injectable Peptides Revenue Market Share by Type (2020-2025)

Table 25. Global Injectable Peptides Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Injectable Peptides Revenue Market Share by Type (2026-2031)

Table 27. Global Injectable Peptides Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Injectable Peptides Revenue Market Share by Application (2020-2025)

Table 29. Global Injectable Peptides Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Injectable Peptides Revenue Market Share by Application (2026-2031)

Table 31. North America Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Injectable Peptides Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Injectable Peptides Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Injectable Peptides Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Injectable Peptides Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Injectable Peptides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Injectable Peptides Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Injectable Peptides Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Injectable Peptides Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Injectable Peptides Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Injectable Peptides Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Injectable Peptides Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Injectable Peptides Product

Table 49. Sanofi Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Teva Company Details

Table 52. Teva Business Overview

Table 53. Teva Injectable Peptides Product

Table 54. Teva Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 55. Teva Recent Development

Table 56. Novo Nordisk Company Details

Table 57. Novo Nordisk Business Overview

Table 58. Novo Nordisk Injectable Peptides Product

Table 59. Novo Nordisk Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 60. Novo Nordisk Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Injectable Peptides Product

Table 64. Takeda Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Eli Lilly Company Details

Table 67. Eli Lilly Business Overview

Table 68. Eli Lilly Injectable Peptides Product

Table 69. Eli Lilly Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 70. Eli Lilly Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Injectable Peptides Product

Table 74. AstraZeneca Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Injectable Peptides Product

Table 79. Novartis Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Injectable Peptides Product

Table 84. AbbVie Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 85. AbbVie Recent Development

Table 86. Ipsen Company Details

Table 87. Ipsen Business Overview

Table 88. Ipsen Injectable Peptides Product

Table 89. Ipsen Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 90. Ipsen Recent Development

Table 91. Ferring Company Details

Table 92. Ferring Business Overview

Table 93. Ferring Injectable Peptides Product

Table 94. Ferring Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 95. Ferring Recent Development

Table 96. Merck Company Details

Table 97. Merck Business Overview

Table 98. Merck Injectable Peptides Product

Table 99. Merck Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 100. Merck Recent Development

Table 101. The Medicines Company Details

Table 102. The Medicines Business Overview

Table 103. The Medicines Injectable Peptides Product

Table 104. The Medicines Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 105. The Medicines Recent Development

Table 106. Roche Company Details

Table 107. Roche Business Overview

Table 108. Roche Injectable Peptides Product

Table 109. Roche Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 110. Roche Recent Development

Table 111. J & J Company Details

Table 112. J & J Business Overview

Table 113. J & J Injectable Peptides Product

Table 114. J & J Revenue in Injectable Peptides Business (2020-2025) & (US$ Million)

Table 115. J & J Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Injectable Peptides Picture

Figure 2. Global Injectable Peptides Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Injectable Peptides Market Share by Type: 2024 VS 2031

Figure 4. Brand Features

Figure 5. Generic Drug Features

Figure 6. Global Injectable Peptides Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Injectable Peptides Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Metabolic Disorders Case Studies

Figure 10. Central Nervous System Case Studies

Figure 11. Other Case Studies

Figure 12. Injectable Peptides Report Years Considered

Figure 13. Global Injectable Peptides Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Injectable Peptides Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Injectable Peptides Market Share by Region: 2024 VS 2031

Figure 16. Global Injectable Peptides Market Share by Players in 2024

Figure 17. Global Top Injectable Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Injectable Peptides Revenue in 2024

Figure 19. North America Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Injectable Peptides Market Share by Country (2020-2031)

Figure 21. United States Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Injectable Peptides Market Share by Country (2020-2031)

Figure 25. Germany Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Injectable Peptides Market Share by Region (2020-2031)

Figure 33. China Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Injectable Peptides Market Share by Country (2020-2031)

Figure 41. Mexico Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Injectable Peptides Market Share by Country (2020-2031)

Figure 45. Turkey Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Injectable Peptides Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Sanofi Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 49. Teva Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 50. Novo Nordisk Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 52. Eli Lilly Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 55. AbbVie Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 56. Ipsen Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 57. Ferring Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 59. The Medicines Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 60. Roche Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 61. J & J Revenue Growth Rate in Injectable Peptides Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide based Generics Market Research Report 2024

Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Drugs Market Research Report 2024

Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injection Peptide Drug Market Research Report 2025

Peptide Antibiotics Sterile Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Therapeutic Peptide APIs Market Research Report 2024

Global Protein and Peptide Therapeutics Market Research Report 2025

Global Biologic Peptide API Market Research Report 2024

Global Peptide APIs Market Insights Forecast to 2030

Global Injectable Drug Delivery Market Research Report 2024

Global Peptide Drugs for Diabetes Market Research Report 2024

Global Peptide Building Block Market Insights Forecast to 2030

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Hospital Injectable Drugs Market Research Report 2024

Global Peptide Supplement Market Research Report 2024

Global Targeting Peptides Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions